Skip directly to content

MedWorm Lung Transplant

Subscribe to MedWorm Lung Transplant feed
MedWorm.com provides a medical RSS filtering service. Thousands of medical RSS feeds are combined and output via different filters. This feed contains the latest news in Lung Transplant
Updated: 1 hour 51 min ago

He lost his sight to cancer, but not his vision of a full life

Thu, 04/20/2017 - 11:00
When Tim Conners collected his wish from the Make-A-Wish Foundation in 2012 at the age of 18, he was blind from childhood leukemia that had spread to his optic nerve and craving inspiration to transcend his disability. A football player and wrestler who’d never been an outdoorsman, he asked to meet Erik Weihenmayer, the first blind person to climb the Seven Summits, the highest mountains on seven continents. Tim’s wish came true. He had 2½ terrifying but transformative days of outdoor adventures in Colorado with Erik, who lost his sight to a degenerative eye disorder at 13. Now Tim is training to climb Mount Kilimanjaro, the 19,000-foot peak in Tanzania in May, shortly after he graduates from Ithaca College. He’s already climbed four peaks in Colorado, including the 14,000-foot...
Categories: Publications

Teen denied lung transplant after smoking pot, family says

Fri, 04/14/2017 - 03:43
19-year-old needed double lung transplant ​, but his family says because he tested positive for chief intoxicant in marijuana​ he was denied spot on list (Source: Health News: CBSNews.com)

MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.

Categories: Publications

Smithfield Makes Move On Market For Pig-Human Transplants

Wed, 04/12/2017 - 16:23
function onPlayerReadyVidible(e){'undefined'!=typeof HPTrack&&HPTrack.Vid.Vidible_track(e)}!function(e,i){if(e.vdb_Player){if('object'==typeof commercial_video){var a='',o='m.fwsitesection='+commercial_video.site_and_category;if(a+=o,commercial_video['package']){var c='&m.fwkeyvalues=sponsorship%3D'+commercial_video['package'];a+=c}e.setAttribute('vdb_params',a)}i(e.vdb_Player)}else{var t=arguments.callee;setTimeout(function(){t(e,i)},0)}}(document.getElementById('vidible_1'),onPlayerReadyVidible); Smithfield Foods, the world’s largest pork producer, has established a separate bioscience unit to expand its role in supplying pig parts for medical uses, with the ultimate goal of selling pig organs for transplantation into humans. Routine pig-human organ transplants are years away, ...
Categories: Publications

ALung closes $36m Series C

Tue, 04/11/2017 - 18:29
Artificial lung-like device developer ALung Technologies said today it closed a $36 million Series C financing round, with funds slated to support a US pivotal trial of its Hemolung respiratory assist system as it pursues FDA approval. The Pittsburgh, Penn.-based company is developing the Hemolung device, an extracorporeal carbon dioxide removal system that works by removing carbon dioxide and delivering oxygen directly to a patient’s blood via a small catheter inserted into the jugular or femoral vein. The funding round was led by Royal Philips (NYSE:PHG) and UPMC and joined by Abiomed (NSDQ:ABMD), The Accelerator Fund, Allos Ventures, Birchmere Ventures, Blue Tree Ventures and Riverfront Ventures. “Since 2013, hundreds of patients with acute respiratory failure have been succes...
Categories: Publications

Local biotech firm raises $36M in round led by Philips, UPMC

Tue, 04/11/2017 - 07:28
ALung Technologies Inc., a Pittsburgh-based developer of an artificial lung device, has closed on $36 million in a Series C financing round led by Philips and UPMC, its largest capital raise to date. The money will support a U.S.-based pivotal trial for Food and Drug Administration approval of ALung’s Hemolung Respiratory Assist System. Both UPMC, which invested through its innovation and commercialization arm UPMC Enterprises, and Philips will offer resources and expertise to support ALung ’s… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Categories: Publications

Donor-Derived DNA Predicts Lung Transplant Rejection Donor-Derived DNA Predicts Lung Transplant Rejection

Mon, 04/10/2017 - 17:32
Before any clinical signs of graft failure are evident in patients who undergo lung transplant, experimental research suggests that donor-derived cell-free DNA could help predict a poor outcome.Medscape Medical News (Source: Medscape Medical News Headlines)
Categories: Publications

The Boston Marathon: Brave and beyond

Mon, 04/10/2017 - 11:00
Brave. It’s the word inscribed on the simple band Mary Tremper wears on her left wrist. The band is a reminder from her son Shane that she possesses the strength and courage to bravely face the future. When Mary, a Boston Children’s Hospital Miles for Miracles runner, found the band in the hospital gift shop she knew it was from Shane. And as Mary has shared her son’s story with her teammates and listened to theirs, they have redefined brave, together. A few of their stories, including the Tremper’s, follow. Brave: Remembering Shane Shane in the Boston Children’s NICU. “I run for Shane. I run because he can’t. I run because I can. I run for Shane.” This is Mary Tremper’s mantra. Shane, born May 6, 2016, was the Tremper’s second beautiful baby boy. The day af...
Categories: Publications

'When I met Chloe she was dead': one girl, four hearts and an NHS miracle

Mon, 04/10/2017 - 09:55
Chloe Narbonne ’s heart failed when she was 11, starting a near-hopeless fight for survival. A year on from groundbreaking surgery, she is alive and this is her storyRevealed: girl of 13 is first child in Britain to receive artificial heart“By the time I met Chloe she was dead,” André Simon says matter-of-factly. “I told her parents clearly that she didn’t really have a chance to survive. What I was proposing gave her a theoretical chance.” He pauses. “But I also said that the operation might just prolong her agony and su ffering – I didn’t even know if she would survive it – and that it was OK just to let her go.”Simon, one of the world ’s leading heart and lung specialists, is recalling the conversation he had at the beginning of May last year with Fabienne Narbo...
Categories: Publications

Revealed: girl of 13 is first child in Britain to receive artificial heart

Mon, 04/10/2017 - 09:27
Daring operation saved Chloe Narbonne after a failed transplant meant the device was the only way to keep her aliveChloe ’s story: one girl, four hearts and an NHS miracleA 13-year-old girl from Worcester is the first child in Britain to have received an artificial heart, the Guardian can reveal, after doctors decided it was the only way to save her life.Chloe Narbonne had the device installed in a complex nine-hour operation that involved 30 NHS staff at the Royal Brompton, a specialist heart and lung hospital in London. The artificial heart kept the then 12-year-old girl alive until a human heart became available a few weeks later.Continue reading... (Source: Guardian Unlimited Science)
Categories: Publications

The Time is Now to Move Far Beyond the Pill

Mon, 04/10/2017 - 06:15
There has been a lot of talk about ‘beyond the pill'strategies for many years, as companies create services and solutions that are complementary to their drugs. More recently, with the many changes affecting healthcare, pharma companies are adjusting their business models and looking at strategies to improve patient outcomes and diversify revenue sources that go far beyond the pill.Wellness programs and chronic disease management are common approaches, offering opportunities for companies to increase customer engagement leading to improved outcomes. For example, Biogen has used Fitbits to monitor the walking activity of patients with multiple sclerosis, previously only measured during visits to the doctor ’s office.This is a good example of an integrated solution that help patients ach...
Categories: Publications

ISHLT 2017: Medtronic HVAD trial misses primary endpoint, reports lowered stroke rates

Wed, 04/05/2017 - 18:37
Medtronic (NYSE:MDT) said today that results from the Endurance supplemental trial of its HVAD heart pump system did not meet its primary endpoint, but did report  lowered stroke rates compared to standard treatment. The trial aimed to evaluate the use of the HVAD system, which it picked up along with HeartWare last year, as a destination therapy for patients who require a left ventricular assist device and received improved blood pressure management, the Fridley, Minn.-based company said. Data from the study was presented at the 2017 International Society for Heart and Lung Transplantation Scientific Meeting in San Diego. Medtronic said that the Endurance trial did not meet its primary endpoint of all neurologic events at 12 months, but that secondary results indicated a 76.4% survival ...

MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.

Categories: Publications

Mechanical Circulatory Support Trials to Star at ISHLT 2017 Mechanical Circulatory Support Trials to Star at ISHLT 2017

Thu, 03/30/2017 - 18:33
Highly anticipated findings from the latest trials of new left ventricular assist devices will be presented at the heart and lung transplantation meeting.Medscape Medical News (Source: Medscape Medical News Headlines)
Categories: Publications

Samsung NeuroLogica, MedyMatch to collaborate

Thu, 03/30/2017 - 16:33
Samsung NeuroLogica and artificial intelligence (AI) developer MedyMatch have...Read more on AuntMinnie.comRelated Reading: NeuroLogica launches mobile lung CT unit IBM Watson deal puts MedyMatch on the map Samsung lands HealthTrust deal MedyMatch debuts AI for detecting intracranial bleeding Samsung NeuroLogica adds Fla. CT installation AI developer adds to scientific, medical advisory board (Source: AuntMinnie.com Headlines)
Categories: Publications

Samsung NeuroLogica, MedyMatch to partner

Thu, 03/30/2017 - 06:00
Samsung NeuroLogica and artificial intelligence (AI) developer MedyMatch have...Read more on AuntMinnie.comRelated Reading: NeuroLogica launches mobile lung CT unit IBM Watson deal puts MedyMatch on the map Samsung lands HealthTrust deal MedyMatch debuts AI for detecting intracranial bleeding Samsung NeuroLogica adds Fla. CT installation AI developer adds to scientific, medical advisory board (Source: AuntMinnie.com Headlines)
Categories: Publications

Duke ’s short lung transplant list saves CF patient

Wed, 03/29/2017 - 19:29
Treatment TermsCystic fibrosisPulmonary rehabilitationLung transplant CategoriesAdvanced treatments SEO Meta Description Cystic fibrosis patient Aimee Driscoll was given just hours to live. With no donor lungs available near her home in Maine, she was flown to Duke. Author MaryAnn Fletcher Overview Cystic fibrosis patient Aimee Driscoll was given just hours to live. With no donor lungs available near her home in Maine, she was flown to Duke. Hero Imageaimee_driscoll_blog.jpg Preview Image Content Blocks Section Header Image/Videoaimee_driscoll_blog2b.jpg Section Features Images/Media Text Content Header High-volume lung transplant center, shorter wait times ContentDuke ’slung transplant center, the highest-volume center in the Southeast, generally has shorter wait times ...
Categories: Publications

International Society of Heart and Lung Transplantation International Society of Heart and Lung Transplantation

Wed, 03/29/2017 - 16:53
Read clinically focused news coverage of key developments from ISHLT 2017.theheart.org on Medscape (Source: Medscape Today Headlines)

MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.

Categories: Publications

Pioneering stem cell gene therapy cures infants with bubble baby disease

Mon, 03/27/2017 - 19:18
FINDINGSUCLA researchers have developed a stem cell gene therapy cure for babies born with adenosine deaminase-deficient severe combined immunodeficiency, a rare and life-threatening condition that can be fatal within the first year of life if left untreated.In a phase 2 clinical trial led by Dr. Donald Kohn of the  Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA, all nine babies were cured. A 10th trial participant was a teenager at the time of treatment and showed no signs of immune system recovery. Kohn’s treatment method, a stem cell gene therapy that safely restores immune systems in babies with the immunodeficiency using the child’s own c ells, has cured 30 out of 30 babies during the course of several clinical trials.BACKGROUNDAdenosine deam...
Categories: Publications

Clinical Laboratories Could Soon Diagnose 17 Diseases with a Single Breath Analyzer Test from Israel ’s Institute of Technology

Fri, 03/24/2017 - 09:00
The Technion breathalyzer would give pathology groups and medical laboratories unprecedented ability to support physicians in diagnosing and treating cancers, chronic diseases, and other illnesses Readers of Dark Daily know that several pathology research teams in America and the UK are developing breath analyzer tests that can detect everything from lung cancer to early-stage infections. Clinical […] (Source: Dark Daily)
Categories: Publications

Artificial Lungs in a Backpack?

Thu, 03/23/2017 - 12:58
Thu, 03/23/2017 - 13:58News blog (Source: The Aspergillus Website - updates)
Categories: Publications

Cryogenic preservation: from single cells to whole organs – Science Weekly podcast

Wed, 03/22/2017 - 11:59
Hannah Devlin looks at recent advances in the field ofcryopreservation and asks how close we are to applying these technologies to whole organsSubscribe& Review oniTunes,Soundcloud,Audioboom,Mixcloud&Acast, and join the discussion onFacebook andTwitterLast year, around 3,500 organs were transplanted into patients in the UK alone. That said, a large number of organs were also discarded because the moment a donor dies, doctors have only eight or so hours to find a patient on the organ register who is a match and can be almost immediately ready for surgery. One recent estimate suggested that as many as 60% of the hearts and lungs donated for transplantation are discarded each year. But a new technology could be about to change this: whole-organ cryopreservation.Continue reading... (So...
Categories: Publications

Pages